This site is intended for health professionals only

Guidance on insulin pump therapy


The National Institute for Health and Clinical Excellence (NICE) has recommended the use of insulin pump therapy to treat type 1 diabetes in children over 12.

The recommendation comes in NICE’s final guidance, issued as a result of a review of guidance on the use of continuous subcutaneous insulin infusion (CSII) therapy first published in February 2003.

It recommends insulin pump therapy as a treatment option in patients over the age of 12 provided that attempts to reach target haemoglobin A1c (HbA1c) levels with multiple daily injections result in the person having ‘disabling hypoglycaemia’, or if HbA1c levels have remained high (8.5% or above) with multiple daily injections despite the person and/or their carer carefully trying to manage their diabetes.

Insulin pump therapy should only be continued in adults and children 12 years and over if there has been a sustained improvement in the control of their blood glucose levels, NICE added.

For children under 12 years with type 1 diabetes, the guidance recommends the use of insulin pump therapy as a possible treatment if treatment with multiple daily injections is not practical or is not considered appropriate. Insulin pump therapy is not recommended for the treatment of people with type 2 diabetes.

Copyright PA Business 2008


Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine